The effect of radiological contrast media on renal function and inflammatory markers in people with diabetes – a clinical study and review

Mark Baxter, Catherine Gooday, Ketan Dhatariya

Abstract


Aim: To assess the association of inflammatory markers and the risk of developing contrast-induced nephropathy (CIN) in patients with diabetes undergoing lower limb angiography.

Methods: This was a retrospective study of 77 patients undergoing lower limb angiography. We measured renal function and markers of inflammation, in particular neutrophil and lymphocyte count and C-reactive protein (CRP) levels, before and at 24, 48 and 72 hours after administration of contrast medium.

Results: Those with pre-existing renal disease were at increased risk of CIN. We found no relationship between baseline renal function and CRP. There was a reduction in haemoglobin and lymphocyte count that is currently unexplained.

Conclusions: While several traditional risk factors for CIN have been identified, further work is needed to determine the significance of changes in other haematological parameters.

Full Text:

HTML PDF

References


Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 1994;331:1449-50. http://dx.doi.org/10.1056/NEJM199411243312111

Tublin ME, Murphy ME, Tessler FN. Current concepts in contrast media-induced nephropathy. Am J Roentgenol 1998;171:933-9. http://dx.doi.org/10.2214/ajr.171.4.9762972

Mehran R, Nikolsky E. Contrast-induced nephropathy: Definition, epidemiology, and patients at risk. Kidney Int 2006;69:S11-15. http://dx.doi.org/10.1038/sj.ki.5000368

Renal Association, Royal College of Radiologists, and British Cardiovascular Intervention Society. Prevention of contrast induced acute kidney injury (CI-AKI) in adult patients. 2013. Available at https://www.rcr.ac.uk/sites/default/files/publication/2013_RA_BCIS_RCR.pdf (last accessed June 29 2015).

Gallagher S, Knight C. Contrast-induced nephropathy in primary percutaneous coronary intervention. Heart 2011;97:1723-5. http://dx.doi.org/10.1136/heartjnl-2011-300517

Russo D, Minutolo R, Cianciaruso B, et al. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 1995;6:1451-8.

Mehran R, Ayming ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 2004;44:1393-9. http://dx.doi.org/10.1016/j.jacc.2004.06.068

Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol 2004;83:673-89. http://dx.doi.org/10.2214/ajr.183.6.01831673

McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-75. http://dx.doi.org/10.1016/S0002-9343(97)00150-2

Evola S, Lunetta M, Macaione F, et al. Risk factors for contrast induced nephropathy: A study among Italian patients. Indian Heart J 2014; 64:484-91. http://dx.doi.org/10.1016/j.ihj.2012.07.007

Liu Y, Tan N, Zhou Y-L, et al. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention. J Nephrol 2012;25:332-40. http://dx.doi.org/10.5301/jn.5000007

Schwedler SB, Kuhlencordt PJ, Ponnuswamy PP, et al. Native C-reactive protein induces endothelial dysfunction in ApoE -/- mice: Implications for iNOS and reactive oxygen species. Atherosclerosis 2007;195:e76-84. http://dx.doi.org/10.1016/j.atherosclerosis.2007.06.013

Haffner SM. Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol 2003;92:18-26J. http://dx.doi.org/10.1016/S0002-9149(03)00612-X

Royal College of Radiologists. Metformin: Updated guidance for use in diabetics with renal impairment. http://www.rcn.org.uk/__data/assets/pdf_file/0011/258743/BFCR097_Metformin.pdf. 2009 (last accessed June 29 2015)

Persson PB, Tepel M. Contrast medium-induced nephropathy: The pathophysiology. Kidney Int 2014;69:S8-10. http://dx.doi.org/10.1038/sj.ki.5000367

Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68:14-22. http://dx.doi.org/10.1111/j.1523-1755.2005.00377.x

Deray G, Martinez F, Cacoub P, et al. A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol 1990;10:316-22. http://dx.doi.org/10.1159/000168126

Hall KA, Wong RW, Hunter GC, et al. Contrast-induced nephrotoxicity: The effects of vasodilator therapy. J Surg Res 1992;53:317-20. http://dx.doi.org/10.1016/0022-4804(92)90054-4

Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 1989;320:143-9. http://dx.doi.org/10.1056/NEJM198901193200303

Lautin EM, Freeman NJ, Schoenfeld AH, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. Am J Roentgenol 2014; 57:49-58.

Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-64. http://dx.doi.org/10.1161/01.CIR. 0000016043.87291.33

Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology 1997;203:605-610. http://dx.doi.org/10.1148/radiology.203.3.9169676

Nikolsky E, Mehran R, Turcot D, et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004;94:300-05. http://dx.doi.org/10.1016/j.amjcard.2004.04.023

Kwasa EA, Vinayak S, Armstrong R. The role of inflammation in contrast-induced nephropathy. Br J Radiol 2014;87:20130738. http://dx.doi.org/10.1259/bjr.20130738

Kaya A, Kurt M, Tanboga IH. Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention. Angiology 2014;65:59. http://dx.doi.org/10.1177/0003319713502847

Mansi IA. In vitro effects of coronary angiography: Unknown clinical implications. Med Hypotheses 2009;73:389-92. http://dx.doi.org/10.1016/j.mehy.2009.02.035

Feldman LJ, Chollet-Martin S, Himbert D, et al. Modulation of the expression of the granulocyte adhesion molecule, CR3, by percutaneous transluminal coronary angioplasty and contrast media. Invest Radiol 1994;29:313-18. http://dx.doi.org/10.1097/00004424-199403000-00011

Antunez C, Barbaud A, Gomez E, et al. Recognition of iodixanol by dendritic cells increases the cellular response in delayed allergic reactions to contrast media. Clin Exp Allergy 2011;41:657-64. http://dx.doi.org/10.1111/j.1365-2222.2010.03693.x

Gomez E, Ariza A, Blanca-Lopez N, et al. Nonimmediate hypersensitivity reactions to iodinated contrast media. Curr Opin Allergy Clin Immunol 2013;13:345-353. http://dx.doi.org/10.1097/ACI.0b013e328362b926

McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 2004;20:1501-10. http://dx.doi.org/10.1185/030079904X2763

Morabito S, Pistolesi V, Benedetti G, et al. Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography. J Nephrol 2012;25:1098-107. http://dx.doi.org/10.5301/jn.5000101

Idee JM, Beaufils H, Bonnemain B. Iodinated contrast media-induced nephropathy: pathophysiology, clinical aspects and prevention. Fundamental & Clinical Pharmacology 1994;8:193-206. http://dx.doi.org/10.1111/j.1472-8206.1994.tb00799.x




DOI: https://doi.org/10.15277/bjdvd.2015.040

Refbacks

  • There are currently no refbacks.


The Journal of the Association of British Clinical Diabetologists